Article Text
Airwaves
airwaves
Statistics from Altmetric.com
COMBINATION ANTI-INFLAMMATORY THERAPY IN COPD
We now know from the recent TORCH data that long acting β2 agonists, inhaled corticosteroids and the combination of these treatments all reduce exacerbations in patients with COPD. However, the relative anti-inflammatory activity of these different treatments has not been fully evaluated. In this month’s Thorax, Bourbeau and colleagues report on a study comparing the effect of the inhaled salmeterol/fluticasone (SFC) combination with inhaled fluticasone (FP) and placebo on airway inflammation. SFC reduced airway CD8+ cells compared with placebo, but this effect was not seen with FP alone. CD68+ macrophages were also reduced by SFC …
Linked Articles
- Editorial
- Chronic obstructive pulmonary disease
- Chronic obstructive pulmonary disease
- Intensive care
- Smoking